Literature DB >> 10642756

Acute and late outcome after use of 2.5-mm intracoronary stents in small (< 2.5 mm) coronary arteries.

P Huang1, T Levin, A Kabour, T Feldman.   

Abstract

We describe the high-pressure deployment of 2.5-mm stents in small (< 2.5 mm) coronary vessels. Forty-three lesions in 40 patients were treated. The mean reference vessel diameter was 2.3 +/- 0.2 mm. The mean % luminal stenosis was 90 +/- 9. The mean lesion length was 11. 7 +/- 9.1 mm. Sixteen lesions were pretreated with rotational atherectomy, and the remainder with PTCA. The rate of successful stent deployment was 41/43 (95%). The mean postintervention % stenosis was -1 +/- 10. There were no in-hospital deaths or procedure-related Q-wave MI. The patients were followed for a mean of 18 months. Eight patients (or 21%) developed recurrent chest pain and/or angiographically proven restenosis. One patient (3%) developed intermediate restenosis. Twenty-nine patients (or 76%) either remain symptom-free or have patent target sites on repeat angiography. It appears that reasonable acute and long-term results can be achieved with 2.5-mm stents in small coronary arteries using high-pressure deployment techniques. Cathet. Cardiovasc. Intervent. 49:121-126, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10642756     DOI: 10.1002/(sici)1522-726x(200002)49:2<121::aid-ccd1>3.0.co;2-x

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  2 in total

1.  Middle cerebral artery stenosis: endovascular and surgical options.

Authors:  Jeffrey D Klopfenstein; Francisco A Ponce; Louis J Kim; Felipe C Albuquerque; Peter Nakaji; Robert F Spetzler
Journal:  Skull Base       Date:  2005-08

2.  Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome.

Authors:  J K Kim; J Y Ahn; B H Lee; Y S Chung; S S Chung; O J Kim; W C Kim; J Y Joo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.